
Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Archaeologists identify contents of ancient Mayan drug containers
Archaeologists used new methods to identify contents of Mayan drug containers, discovering a non-tobacco plant.
Potential cause of unexplained epilepsy cases uncovered
University of Arizona researchers have uncovered a protein that might be behind some epilepsy cases with currently unknown causes.
“Soft CRISPR” is safer and could help cure more diseases
A new CRISPR system was far more effective and precise than CRISPR-Cas9 when tested in fruit flies.
The first FDA-approved clinical trial of psilocin has begun
“This has never been done before,” says Filament’s CEO.
Nasal COVID-19 vaccines prepare for infection right where it starts – in your nose and throat
Intranasal vaccines are best suited to protect against pathogens that enter through the nose, like the flu or the coronavirus.
FDA authorizes new COVID-19 vaccine — and it’s not like the others
The FDA has issued an emergency use authorization for biotech company Novavax’s protein-based COVID-19 vaccine.
People who read live longer than those who don’t, Yale researchers say
A study by Yale researchers finds that reading books in particular returns cognitive gains that increase longevity.
CRISPR cure for high cholesterol enters first human trial
A trial testing a new CRISPR-based treatment to lower cholesterol has officially kicked off in New Zealand.
After death, you’re aware that you’ve died, say scientists
How can we know that we’re dead after we die? Some evidence attributes a certain neurological phenomenon to a near death experience.
NYU performs two more pig-to-human heart transplants
Two pig-to-human heart transplants performed by surgeons at NYU Langone Health showed all the signs of success.
A historian identifies the worst year in human history
The year 536 ushered in the coldest decade in thousands of years and started a century of economic devastation.
An old HIV drug may treat Down syndrome
A common HIV drug could potentially be a Down syndrome treatment, improving cognition in mouse models of the condition.
New discoveries are rewriting the rulebook for regenerating limbs
Human limb regeneration is closer to reality thanks to new studies that refine our understanding of what mammals need to regrow body parts.
Nanoparticles may automatically clean your teeth one day
Shapeshifting nanoparticles may one day lead to automated oral care.
FDA may soon allow pig organ transplant trials
With pig transplantation looking increasingly viable, the FDA may soon allow clinical trials of the technique to begin.
10-second balance test is a powerful predictor of death for older adults
Adults aged 51-75 who were unable to balance on one foot for ten seconds had an 84% higher risk of death than their peers who could.
Psychedelic research returns to Veterans Affairs
After decades, the Department of Veterans Affairs is once again investigating psychedelic therapies.
Universal flu vaccine enters phase 1 trials
NIAID researchers have begun a phase 1 trial of a new universal vaccine candidate that was promising in animal challenge studies.
A new delivery method for drugs that can’t withstand stomach acid
In order for a drug to get to the small intestine, it must first get past the highly acidic environment of the stomach.
Two FDA-approved drugs may improve Alzheimer’s symptoms
A retrospective study found that Alzheimer’s symptoms improved in patients who took two FDA-approved drugs that treat psychiatric disorders.
Get inspired with the most innovative stories shaping the world around us.